Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manja Meggendorfer

Showing results (81-90 of 125) with videos related to

Pageof 13
Sort By:
Blood Advances|September 29, 2020
Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AMLHidemasa Matsuo, Kenichi Yoshida, Kana Nakatani, et al.
Leukemia|May 26, 2018
Consequences of mutant TET2 on clonality and subclonal hierarchyCassandra M Hirsch, Aziz Nazha, Kassy Kneen, et al.
Life Science Alliance|April 14, 2025
STAT5B leukemic mutations, altering SH2 tyrosine 665, have opposing impacts on immune gene programsHye Kyung Lee, Jichun Chen, Rachael L Philips, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Prognostic score including gene mutations in chronic myelomonocytic leukemiaRaphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
Blood|July 8, 2016
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemiaChiara Elena, Anna Gallì, Esperanza Such, et al.
Blood|May 9, 2019
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasmsFiorella Schischlik, Roland Jäger, Felix Rosebrock, et al.
Leukemia|July 20, 2024
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomesJohann-Christoph Jann, Christopher B Hergott, Marisa Winkler, et al.
Blood Advances|September 30, 2021
A geno-clinical decision model for the diagnosis of myelodysplastic syndromesNathan Radakovich, Manja Meggendorfer, Luca Malcovati, et al.
Blood|June 2, 2021
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemiaHassan Awada, Arda Durmaz, Carmelo Gurnari, et al.
Frontiers in Immunology|October 31, 2022
Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19Judith Schenz, Katharina Rump, Benedikt Hermann Siegler, et al.
Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
Blood Advances|September 29, 2020
Fusion partner-specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AMLHidemasa Matsuo, Kenichi Yoshida, Kana Nakatani, et al.
Leukemia|May 26, 2018
Consequences of mutant TET2 on clonality and subclonal hierarchyCassandra M Hirsch, Aziz Nazha, Kassy Kneen, et al.
Life Science Alliance|April 14, 2025
STAT5B leukemic mutations, altering SH2 tyrosine 665, have opposing impacts on immune gene programsHye Kyung Lee, Jichun Chen, Rachael L Philips, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2013
Prognostic score including gene mutations in chronic myelomonocytic leukemiaRaphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
Blood|July 8, 2016
Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemiaChiara Elena, Anna Gallì, Esperanza Such, et al.
Blood|May 9, 2019
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasmsFiorella Schischlik, Roland Jäger, Felix Rosebrock, et al.
Leukemia|July 20, 2024
Subunit-specific analysis of cohesin-mutant myeloid malignancies reveals distinct ontogeny and outcomesJohann-Christoph Jann, Christopher B Hergott, Marisa Winkler, et al.
Blood Advances|September 30, 2021
A geno-clinical decision model for the diagnosis of myelodysplastic syndromesNathan Radakovich, Manja Meggendorfer, Luca Malcovati, et al.
Blood|June 2, 2021
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemiaHassan Awada, Arda Durmaz, Carmelo Gurnari, et al.
Frontiers in Immunology|October 31, 2022
Increased prevalence of clonal hematopoiesis of indeterminate potential in hospitalized patients with COVID-19Judith Schenz, Katharina Rump, Benedikt Hermann Siegler, et al.
Pageof 13